Saturday, 16 November 2013
Contact Us
Search
Home
About us
Corporate Overview
History
Management Team
Advisory Boards
Partnering & Licensing
Contact
Contact Us
Impressum
News
Current News
Current Publications
News Archive
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
Publications Archive
RESprotect Publications
Other relevant Publications
Newsletter
Chemogenomics
Product Portfolio
Pipeline Summary
RP101
RP101 Inhibition
Hsp27
Key Effects
Interaction
Hsp27 Suppression
Pancreatic Cancer
The Role of Hsp27
Clinical Effects of RP101
Summary of Clinical Trials
Competitive Advantage
2nd Generation
Navigation
Current News
Current Publications
News Archive
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
Publications Archive
RESprotect Publications
Other relevant Publications
Newsletter
Home
News
News Archive
2007
News 2007
Filter
Order
Date asc
Date desc
Title asc
Title desc
Hits asc
Hits desc
Author asc
Author desc
Ordering
Display #
5
10
15
20
25
30
50
Date
Title
Author
Hits
Thu, 01 Nov 2007
RP101 Orphan Drug Designation
RESprotect GmbH
2832
Sat, 18 Aug 2007
5 Jahre futureSAX: Auszeichnung der Sieger
futureSAX GmbH Dresden
7503
Mon, 07 May 2007
RESprotect grants License for RP101 to SciClone
RESprotect GmbH
4433
<< Start
< Prev
1
Next >
End >>
Results 1 - 3 of 3
News 2011
( 4 items )
News 2010
( 2 items )
News 2009
( 4 items )
News 2008
( 8 items )
News 2006
( 8 items )
News 2005
( 8 items )
News 2004
( 7 items )
News 2003
( 1 items )
News 2002
( 2 items )
News 2001
( 2 items )
News 2000
( 4 items )
News 1999
( 5 items )
News 1998
( 1 items )
[ Back ]